Compare RCUS & CALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | CALM |
|---|---|---|
| Founded | 2015 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.0B |
| IPO Year | 2018 | 1996 |
| Metric | RCUS | CALM |
|---|---|---|
| Price | $24.23 | $74.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $31.90 | ★ $92.00 |
| AVG Volume (30 Days) | ★ 1.4M | 866.3K |
| Earning Date | 05-05-2026 | 04-01-2026 |
| Dividend Yield | N/A | ★ 11.13% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.63 |
| Revenue | $247,000,000.00 | ★ $2,911,632,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.62 | N/A |
| P/E Ratio | ★ N/A | $11.22 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.58 | $71.92 |
| 52 Week High | $31.74 | $108.80 |
| Indicator | RCUS | CALM |
|---|---|---|
| Relative Strength Index (RSI) | 25.83 | 35.27 |
| Support Level | $23.91 | $73.42 |
| Resistance Level | $24.33 | $80.00 |
| Average True Range (ATR) | 1.31 | 2.08 |
| MACD | -0.71 | -0.48 |
| Stochastic Oscillator | 0.66 | 18.02 |
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Cal-Maine Foods Inc is an egg company in the U.S. Its shell egg portfolio includes conventional, specialty, cage-free, nutritionally enhanced, organic, brown, pasture-raised, and free-range eggs, serving retail and foodservice customers nationwide. It sells its products to national and regional grocery store chains, club stores, companies servicing independent supermarkets in the U.S., and foodservice distributors serving restaurants, convenience stores, healthcare and education facilities, and hotels throughout the majority of the U.S. The Conventional Shell Eggs segment generates maximum revenue and consists mainly of the production, grading, packaging, marketing, and distribution of shell eggs sold as conventional shell eggs.